Hydroxychloroquine in patients with mild COVID-19 illness with risk factors for severe disease
Phase 2
Suspended
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/05/025022
- Lead Sponsor
- AIIMS Department of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients with RT-PCR confirmed mild COVID-19 illness with high risk factors
2.Age > 18 years
3.Written informed consent
Exclusion Criteria
1.Patients without any of the high risk factors for severe illness
2.Pregnant women
3.Known hypersensitivity to HCQ
4.Known Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression to moderate- severe diseaseTimepoint: 6 month
- Secondary Outcome Measures
Name Time Method 1.Time to clinical resolution of symptoms <br/ ><br>2.Incidence of adverse events <br/ ><br>Timepoint: 6 months-Analysis and final report of results